Third Harmonic Bio IncNASDAQ:THRD
- LAST PRICE4.4100
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.2000/ 29
- Ask / Lots4.8000/ 2
- Open / Previous Close0.0000 / 4.4100
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | THRD |
|---|---|---|
| 09:32 ET | 816 | 4.43 |
| 09:33 ET | 145 | 4.3877 |
| 09:37 ET | 100 | 4.38 |
| 09:39 ET | 100 | 4.39 |
| 09:42 ET | 970 | 4.45 |
| 09:44 ET | 1000 | 4.45 |
| 09:46 ET | 100 | 4.44 |
| 09:48 ET | 500 | 4.425 |
| 09:53 ET | 200 | 4.42 |
| 10:04 ET | 200 | 4.435 |
| 10:06 ET | 100 | 4.42 |
| 10:09 ET | 100 | 4.42 |
| 10:11 ET | 200 | 4.44 |
| 10:13 ET | 100 | 4.435 |
| 10:15 ET | 100 | 4.435 |
| 10:20 ET | 1000 | 4.44 |
| 10:27 ET | 100 | 4.46 |
| 10:31 ET | 100 | 4.44 |
| 10:33 ET | 1279 | 4.48 |
| 10:36 ET | 4590 | 4.51 |
| 10:38 ET | 200 | 4.54 |
| 10:40 ET | 200 | 4.54 |
| 10:42 ET | 600 | 4.55 |
| 10:44 ET | 8214 | 4.542 |
| 10:45 ET | 13222 | 4.6 |
| 10:47 ET | 1000 | 4.6 |
| 10:49 ET | 5347 | 4.58 |
| 10:51 ET | 400 | 4.61 |
| 10:54 ET | 500 | 4.63 |
| 10:56 ET | 700 | 4.63 |
| 10:58 ET | 2802 | 4.64 |
| 11:00 ET | 1000 | 4.59 |
| 11:02 ET | 4420 | 4.54 |
| 11:03 ET | 100 | 4.58 |
| 11:05 ET | 100 | 4.56 |
| 11:07 ET | 529 | 4.575 |
| 11:14 ET | 200 | 4.59 |
| 11:16 ET | 100 | 4.575 |
| 11:18 ET | 100 | 4.59 |
| 11:21 ET | 100 | 4.59 |
| 11:27 ET | 100 | 4.5675 |
| 11:32 ET | 11002 | 4.52 |
| 11:34 ET | 600 | 4.5388 |
| 11:36 ET | 1300 | 4.555 |
| 11:38 ET | 200 | 4.57 |
| 11:39 ET | 1318 | 4.55 |
| 11:41 ET | 100 | 4.545 |
| 11:43 ET | 100 | 4.56 |
| 11:48 ET | 300 | 4.56 |
| 11:50 ET | 1100 | 4.54 |
| 11:52 ET | 100 | 4.53 |
| 11:56 ET | 500 | 4.53 |
| 11:57 ET | 200 | 4.54 |
| 11:59 ET | 200 | 4.54 |
| 12:01 ET | 100 | 4.54 |
| 12:03 ET | 400 | 4.54 |
| 12:06 ET | 100 | 4.55 |
| 12:08 ET | 300 | 4.57 |
| 12:15 ET | 500 | 4.53 |
| 12:26 ET | 100 | 4.52 |
| 12:33 ET | 100 | 4.54 |
| 12:35 ET | 100 | 4.54 |
| 12:39 ET | 502 | 4.53 |
| 12:42 ET | 1000 | 4.53 |
| 12:44 ET | 100 | 4.54 |
| 12:46 ET | 1195 | 4.54 |
| 12:48 ET | 315 | 4.555 |
| 12:50 ET | 100 | 4.57 |
| 12:51 ET | 1000 | 4.55 |
| 01:00 ET | 400 | 4.56 |
| 01:06 ET | 300 | 4.56 |
| 01:08 ET | 300 | 4.57 |
| 01:09 ET | 1632 | 4.52 |
| 01:11 ET | 1100 | 4.515 |
| 01:13 ET | 400 | 4.51 |
| 01:15 ET | 800 | 4.5 |
| 01:18 ET | 500 | 4.5 |
| 01:42 ET | 200 | 4.48 |
| 01:45 ET | 1730 | 4.4643 |
| 01:47 ET | 700 | 4.49 |
| 01:56 ET | 100 | 4.49 |
| 01:58 ET | 100 | 4.49 |
| 02:03 ET | 2100 | 4.49 |
| 02:05 ET | 300 | 4.5 |
| 02:07 ET | 2020 | 4.49 |
| 02:09 ET | 100 | 4.49 |
| 02:23 ET | 100 | 4.5 |
| 02:27 ET | 100 | 4.48 |
| 02:32 ET | 600 | 4.48 |
| 02:34 ET | 100 | 4.485 |
| 02:36 ET | 100 | 4.48 |
| 02:38 ET | 300 | 4.48 |
| 02:39 ET | 2422 | 4.47 |
| 02:43 ET | 400 | 4.49 |
| 02:45 ET | 100 | 4.49 |
| 02:48 ET | 1209 | 4.49 |
| 02:50 ET | 1000 | 4.48 |
| 02:54 ET | 100 | 4.49 |
| 02:57 ET | 821 | 4.47 |
| 03:08 ET | 1709 | 4.435 |
| 03:14 ET | 100 | 4.45 |
| 03:15 ET | 100 | 4.45 |
| 03:24 ET | 600 | 4.45 |
| 03:26 ET | 923 | 4.44 |
| 03:28 ET | 100 | 4.45 |
| 03:32 ET | 100 | 4.45 |
| 03:33 ET | 100 | 4.46 |
| 03:35 ET | 100 | 4.44 |
| 03:37 ET | 300 | 4.45 |
| 03:39 ET | 200 | 4.46 |
| 03:42 ET | 100 | 4.46 |
| 03:44 ET | 947 | 4.44 |
| 03:46 ET | 200 | 4.45 |
| 03:48 ET | 100 | 4.45 |
| 03:50 ET | 400 | 4.44 |
| 03:53 ET | 900 | 4.42 |
| 03:55 ET | 400 | 4.41 |
| 03:57 ET | 400 | 4.41 |
| 04:00 ET | 3638 | 4.41 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Third Harmonic Bio Inc | 178.8M | 0.0x | --- |
Trevi Therapeutics Inc | 178.0M | -3.5x | --- |
BioVie Inc | 175.7M | -4.5x | --- |
Olema Pharmaceuticals Inc | 184.1M | -1.8x | --- |
Alaunos Therapeutics Inc | 166.7M | -3.7x | --- |
Spectrum Pharmaceuticals Inc | 164.6M | -1.3x | --- |
Company Information
Third Harmonic Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of medicine for the treatment of allergic and inflammatory diseases. Its lead product candidate, THB001, is a potent and highly selective, oral small molecule wild-type KIT inhibitor in development for the treatment of mast cell-mediated inflammatory diseases. KIT is a cell surface receptor that acts as the master survival and functional regulator of mast cells. Mast cells are a part of the immune system, and dysfunctional mast cell activity has been implicated in the pathophysiology of a range of allergic and other inflammatory disorders including urticaria, asthma and gastrointestinal disorders, among others. It has completed Phase Ia clinical trial for THB001, which has demonstrated dose-dependent reductions of serum tryptase, a key biomarker of mast cell activity, which has been shown to correlate with clinical benefit in chronic urticaria patients.
Contact Information
- Headquarters
- 1700 Montgomery Street, Suite 210SAN FRANCISCO, CA, United States 94111
- Phone
- 209-727-2457
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Mark Iwicki
- Chief Executive Officer, Director
- Natalie Holles
- Chief Financial Officer
- Robert Ho
- Chief Administrative Officer
- Julie Person
- Chief Scientific Officer
- Adrian Ray
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $178.8M |
|---|---|
Revenue (TTM) | --- |
Shares Outstanding | 40.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | --- |
Book Value | $3.19 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
